April 19 price action for many of the Biotech and Genomic names in our watch list was strong. We are early in sharing this but want to get you acclimated to a potential opportunity.
LOTM has been watching this group for some time. They fell from a greatly over-valued price for the entire group in February 2021. Now we are about twenty-seven months later. The stocks have been through the stage four chart pattern. They are now in a stage one chart pattern.
We will use Cathie Wood’s ARK Genomic ETF as a measuring stick for the industry below. One reason we targeted the Genomic industry is that they are literally changing the healthcare world. They move great distances in price, up and down. They appear to have been washed out from their drop in price from Continue reading